ctrl K

Advertisement

RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-72.12M	-39.38M	-6.92M
Interest Income	3.52M	265K	5K
Pretax Income	-68.6M	-29.44M	-6.92M
Net Income	-68.6M	-29.44M	-6.92M
Selling & General & Admin	10.94M	5.5M	1.08M
Research & Development	61.18M	33.88M	5.84M
Other Expenses	n/a	9.67M	n/a
Operating Expenses	72.12M	39.38M	6.92M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	72.12M	39.38M	6.92M
Income Tax Expense	n/a	-265K	n/a
Shares Outstanding (Basic)	39.22M	40.31M	40.31M
Shares Outstanding (Diluted)	39.22M	40.31M	40.31M
EPS (Basic)	-1.75	-0.73	-0.17
EPS (Diluted)	-1.75	-0.73	-0.17
EBITDA	-70.59M	-38.92M	-6.71M
EBIT	n/a	n/a	n/a
Depreciation & Amortization	1.53M	455K	213K